A Review of the Application Progress of Non-Invasive Hemodynamic Monitoring in the Precision Treatment of Hypertension

Abstract

Hypertension affects many patients worldwide, and its precise treatment is the focus of clinical research. Currently, conventional clinical methods for monitoring blood pressure can only intermittently measure systolic and diastolic blood pressure and cannot monitor important hemodynamic parameters such as cardiac output (CO), systemic vascular resistance (SVR), and arterial elasticity, thereby affecting the formulation of individualized treatment plans. In recent decades, the emergence of non-invasive hemodynamic monitoring methods has addressed these clinical challenges. These methods use non-invasive methods to monitor parameters such as cardiac pumping function, vascular resistance, and volume status, helping clinicians better understand the pathophysiology of hypertension and facilitating a shift from “empirical blood pressure reduction” to “precision treatment based on hemodynamics”. This article aims to introduce the technical principles, main parameters, and clinical applications of non-invasive hemodynamic monitoring, with a focus on discussing its clinical value in hypertension classification, formulation of individualized treatment plans, assessment of treatment effects, and management of special populations. Based on this, future application and development directions are proposed, aiming to provide references and evidence for the clinical practice of precise hypertension treatment.

Keywords

Non-invasive hemodynamics / Hypertension / Precision treatment / Monitoring technology / Individualized treatment

References

[1] Cheraghi Z, Azmi—Naei B, Cheraghi P, Doosti—Irani A. The global prevalence of uncontrolled hypertension: A systematic review and meta—analysis. BMC Public Health 2025, 25,4259. DOI:10.1186/s12889—025—25553—4

[2] Li Y, Gu H, Sinha MD, Chowienczyk P. Hemodynamic Characterization of Primary Hypertension in Children and Adolescents. J. Am. Heart Assoc. 2020, 9,e015097. DOI:10.1161/JAHA.119.015097

[3] Li Y, Haseler E, McNally R, Sinha MD, Chowienczyk PJ. A meta—analysis of the haemodynamics of primary hypertension in children and adults. J. Hypertens. 2023, 41,212-219. DOI:10.1097/HJH.0000000000003326

[4] Gyselaers W. Hemodynamic pathways of gestational hypertension and preeclampsia. Am. J. Obstet. Gynecol. 2022, 226,S988-S1005. DOI:10.1016/j.ajog.2021.11.022

[5] Wang L, Lu Y, Wang H, Gu J, Ma ZJ, Lian Z, et al. Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real—world setting: Results from a pragmatic clinical trial. Open Heart 2021, 8,e001719. DOI:10.1136/openhrt—2021—001719

[6] Stępniak P, Cacko A, Kołodzińska A, Grabowski M. Non—invasive methods of cardiac output measurement and their importance in everyday clinical practice: The current state of knowledge. Folia Cardiol. 2021, 16,237-241. DOI:10.5603/FC.2021.0036

[7] Wang A—Y, Chang K—S, Wu Y—L. Non—Invasive Hemodynamic Monitoring in a Collapsed Runner. J. Acute Med. 2025, 15,73. DOI:10.6705/j.jacme.202506_15(2).0006

[8] Scheer P, Hložková J, Brhelová E, Aksu A, Goliášová S, Doležalová J, et al. The Non—Invasive Transcranial Doppler for Hemodynamic Monitoring.Physiol. Res. 2025, 74,393-401. DOI:10.33549/physiolres.935413

[9] Sadrawi M, Lin YT, Lin CH, Mathunjwa B, Hsin HT, Fan SZ, et al. Non—Invasive Hemodynamics Monitoring System Based on Electrocardiography via Deep Convolutional Autoencoder. Sensors 2021, 21,6264. DOI:10.3390/s21186264

[10] Stolte T, Sathananthan J, Reichl JJ, Boeddinghaus J, Wagener M, Schöpflin C, et al. Non—Invasive Hemodynamic Monitoring in Transcatheter Aortic Valve Implantation.J. Clin. Med. 2025, 14,3794. DOI:10.3390/jcm14113794

[11] Gupta P, Moghimi MJ, Jeong Y, Gupta D, Inan OT, Ayazi F. Precision wearable accelerometer contact microphones for longitudinal monitoring of mechano—acoustic cardiopulmonary signals.NPJ Digit. Med. 2020, 3,19. DOI:10.1038/s41746—020—0225—7

[12] Caragață AV, Hnatiuc M, Geman O, Halunga S, Tulbure A, Iov CJ. Smart Devices and Multimodal Systems for Mental Health Monitoring: From Theory to Application.Bioengineering 2026, 13,165. DOI:10.3390/bioengineering13020165

[13] Xu J, Zeng W, Zhao C, Tong J, Liu H. Robust heart rate monitoring by a wearable stethoscope based on signal processing. Sens. Diagn. 2023, 2,657-664. DOI:10.1039/D2SD00227B

[14] Schlesinger DE, Alam R, Ringel R, Pomerantsev E, Devireddy S, Shah P, et al. Artificial intelligence for hemodynamic monitoring with a wearable electrocardiogram monitor. Commun. Med. 2025, 5,4. DOI:10.1038/s43856—024—00730—5

[15] Heinonen I. Cardiac output limits maximal oxygen consumption, but what limits maximal cardiac output? Exp. Physiol. 2025, 110,666-674. DOI:10.1113/EP091594

[16] Alraies MC, Garry DJ, Garry MG. Garry DJ, Wilson RF, Vlodaver Z. Physiology of the Normal and Failing Heart. InCongestive Heart Failure and Cardiac Transplantation: Clinical, Pathology, Imaging and Molecular Profiles ; Springer International Publishing: Cham, Switzerland, 2017; pp. 21-37.

[17] Nahler G. Cardiac index. InDictionary of Pharmaceutical Medicine ; Springer Vienna: Vienna, Austria, 2009; p. 21.

[18] Zhang J, Liang J, Zhang X, Su C, He J, Qiu Y, et al. Non—invasive Systemic Hemodynamic Index in Vascular Risk Stratification Tailored for Hypertensives. Front. Cardiovasc. Med. 2021, 8,744349. DOI:10.3389/fcvm.2021.744349

[19] Guo X, Kassab GS. Increased Serum Klotho with Age—Related Aortic Stiffness and Peripheral Vascular Resistance in Young and Middle—Aged Swine. Front. Physiol. 2020, 11,591. DOI:10.3389/fphys.2020.00591

[20] Koh W, Schneider KA, Zang H, Batlivala SP, Monteleone MP, Benscoter AL, et al. Measurement of Cardiac Output Using an Ultrasonic Cardiac Output Monitor (USCOM) in Patients with Single—Ventricle Physiology. Pediatr. Cardiol. 2022, 43,1205-1213. DOI:10.1007/s00246—022—02840—0

[21] Leão RN, Silva PMD. Impedance Cardiography in the Evaluation of Patients with Arterial Hypertension. Int. J. Cardiovasc. Sci. 2019, 32,61-69. DOI:10.5935/2359—4802.20180048

[22] Viera AJ, Hart L, Gomez Altamirano P, Tuttle B, Price A, Sherwood A. Use of Impedance Cardiography to Guide Blood Pressure Lowering Medication Selection: Systematic Review of Randomized Controlled Trials. Am. J. Hypertens. 2024, 37,916-923. DOI:10.1093/ajh/hpae090

[23] Albakri A. High output heart failure: A review of clinical status—Epidemiology, pathophysiology, diagnosis, prognosis and clinical management.Med. Clin. Arch. 2019, 3,1-10. DOI:10.15761/MCA.1000155

[24] Cai A, Calhoun DA. Resistant hypertension: An update of experimental and clinical findings.Hypertension 2017, 70,5-9. DOI:10.1161/HYPERTENSIONAHA.117.08929

[25] Moura AF, Moura—Neto JA, Rodrigues CIS, Miranda MO, Carvalho TC, Paschoalin Carvalho NP, et al. Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory. SAGE Open Med. 2021, 9,20503121211020892. DOI:10.1177/20503121211020892

[26] Teregulov YE, Mayanskaya SD, Teregulova ET. Determination of differentiated hemodynamics types based on assessment of integral circulation indicators in healthy people and patients with hypertension.Kazan Med. J. 2015, 96,911-917. DOI:10.17750/KMJ2015—911

[27] Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder RE, Kirtane AJ, et al. Changes in 24—Hour Patterns of Blood Pressure in Hypertension Following Renal Denervation Therapy.Hypertension 2019, 74,244-249. DOI:10.1161/HYPERTENSIONAHA.119.13081

[28] Margaritis M, Channon KM, Antoniades C. Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering.Antioxid. Redox Signal. 2014, 20,1198-1215. DOI:10.1089/ars.2013.5430

[29] Sturdivant T, Allen—Thomas K, Allen—Tew K. Beta—blockers and calcium channel blockers. Nurs. Made Incred. Easy 2024, 22,14-21. DOI:10.1097/nme.0000000000000066

[30] Fragasso G, Maranta F, Montanaro C, Salerno A, Torlasco C, Margonato A. Pathophysiologic therapeutic targets in hypertension: a cardiological point of view.Expert Opin. Ther. Targets 2012, 16,179-193. DOI:10.1517/14728222.2012.655724

[31] Lu D, Fang Q, Bibby D, Arora B, Schiller NB. Association of Systemic Vascular Resistance Analog and Cardiovascular Outcomes: The Heart and Soul Study. J. Am. Heart Assoc. 2022, 11,e026016. DOI:10.1161/JAHA.122.026016

[32] Buso G, Agabiti—Rosei C, Lemoli M, Corvini F, Muiesan ML. The Global Burden of Resistant Hypertension and Potential Treatment Options. Eur. Cardiol. 2024, 19,e07. DOI:10.15420/ecr.2023.51

[33] Schiffrin EL, Fisher NDL. Diagnosis and management of resistant hypertension. BMJ 2024, 385,e079108. DOI:10.1136/bmj—2023—079108

[34] Webb AJS, Werring DJ. New Insights Into Cerebrovascular Pathophysiology and Hypertension. Stroke 2022, 53,1054-1064. DOI:10.1161/STROKEAHA.121.035850

[35] Cattermole GN, Leung PYM, Ho GYL, Lau PWS, Chan CPY, Chan SSW, et al. The normal ranges of cardiovascular parameters measured using the ultrasonic cardiac output monitor. Physiol. Rep. 2017, 5,e13195. DOI:10.14814/phy2.13195

[36] Matanes F, Khan MB, Siddiqui M, Dudenbostel T, Calhoun D, Oparil S. An Update on Refractory Hypertension.Curr. Hypertens. Rep. 2022, 24,225-234. DOI:10.1007/s11906—022—01185—6

[37] Pisano A, Iannone LF, Leo A, Russo E, Coppolino G, Bolignano D. Renal denervation for resistant hypertension. Cochrane Database Syst. Rev. 2021,11,CD011499. DOI:10.1002/14651858.CD011499.pub3

[38] Bugeja A, Hundemer G, Hiremath S. Resistant hypertension. CMAJ 2024, 196,E905—E905. DOI:10.1503/cmaj.240206

[39] Gyselaers W, Dreesen P. Maternal hemodynamics assessment: Key to unlocking ignored functionalities of the female circulation. Best Pract. Res. Clin. Obstet. Gynaecol. 2025, 99,102595. DOI:10.1016/j.bpobgyn.2025.102595

[40] Shahrbabaki SS, Liu X, Baumert M. Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes. J. Hypertens. 2024, 42,1615-1623. DOI:10.1097/HJH.0000000000003775

[41] Fine J, Branan KL, Rodriguez AJ, Boonya—ananta T, Ajmal, Ramella—Roman JC, et al. Sources of Inaccuracy in Photoplethysmography for Continuous Cardiovascular Monitoring.Biosensors 2021, 11,126. DOI:10.3390/bios11040126

[42] Nachman D, Eisenkraft A, Rahamim E, Ibrahimli M, Asenov A, Goldstein N, et al. Assessing Cardiac Flow Measurements Using a Noninvasive Photoplethysmography—Based Device Compared to Invasive Pulmonary Artery Catheter.JACC Adv. 2025, 4,102093. DOI:10.1016/j.jacadv.2025.102093

[43] Loeb DF, Bayliss EA, Candrian C, deGruy FV, Binswanger IA. Primary care providers’ experiences caring for complex patients in primary care: A qualitative study. BMC Fam. Pract. 2016, 17,34. DOI:10.1186/s12875—016—0433—z

[44] Ahmed AE, Al—Kinani SM, Alshammari AM, Alharbi RF, Alaydaa GS, Alanazi RM, et al. Artificial Intelligence in Non—invasive Hemodynamic Monitoring: A Systematic Review of Accuracy, Effectiveness, and Clinical Applicability in Cardiology. Cureus 2025, 17,e92792. DOI:10.7759/cureus.92792

[45] McEachron KR, Costantini TW. Invasive and non—invasive monitoring in the ICU. Trauma Surg. Acute Care Open 2025, 10,e001780. DOI:10.1136/tsaco—2025—001780

[46] Beltrame M, Bellan M, Patrucco F, Gavelli F. Non—Invasive Hemodynamic Monitoring in Critically Ill Patients: A Guide for Emergency Physicians. J. Clin. Med. 2025, 14,7002. DOI:10.3390/jcm14197002

[47] Shah S, Kaul A, Nagarkar R, Thorat A. Comparison of invasive blood pressure monitoring vs. non—invasive blood pressure monitoring in critically ill children receiving vasoactive agents—A prospective observational study.Front. Pediatr. 2024, 12,1376327. DOI:10.3389/fped.2024.1376327

[48] Liu Y, Pian—Smith MCM, Leffert LR, Minehart RD, Torri A, Coté C, et al. Continuous measurement of cardiac output with the electrical velocimetry method in patients under spinal anesthesia for cesarean delivery. J. Clin. Monit. Comput. 2015, 29,627-634. DOI:10.1007/s10877—014—9645—8

[49] Jones D, Carty P, Karalapillai D. A four—step model to aid teaching, clinical assessment and communication of circulatory disorders among junior clinicians. Crit. Care Resusc. 2022, 24,294-295. DOI:10.51893/2022.4.POV

[50] Trzeciak B, Gutknecht P, Marek—Trzonkowska N, Molisz A, Czaja R, Siebert J. Non—invasive haemodynamic assessments among hypertensive patients in a routine family doctor’s office. Ann. Agric. Environ. Med. 2022, 29,264-268. DOI:10.26444/aaem/143163

[51] Wang A, Mbikyo MB, Zhang J, Cui N, Li Z. Treatment for Resistant Hypertension Under the Guidance of Pharmacogenomics: A Randomised Controlled Open—Label Trial. J. Coll. Physicians Surg. Pak. 2024, 34,383-389. DOI:10.29271/jcpsp.2024.04.383

[52] Eadon MT, Kanuri SH, Chapman AB. Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment. Expert Rev. Precis. Med. Drug Dev. 2018, 3,33-47. DOI:10.1080/23808993.2018.1420419

[53] Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, et al. Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med. 2014, 40,1795-1815. DOI:10.1007/s00134—014—3525—z